Council Regulation (EC) No 141/ 2000 of 16 December 1999, provides under Article 7(2) for a specific contribution from the Community to the European Medicines Agency, distinct from any other subsidy from the European Union, to be used exclusively to compensate the Agency for fee exemptions for orphan medicinal products.